Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > January 2017

« Previous month

CRF Health receives FDA clearance for next-gen wireless glucometer

19-Jan-2017 - The next-generation wireless glucometer provides rapid testing results on the company’s eCOA platform for clinical trials.

EAG Labs now offering dermal absorption studies

19-Jan-2017 - EAG Laboratories has added dermal absorption studies to its GLP-compliant testing services suite, as part of the company’s plan to continue expanding its capabilities.

Final Rule 'modernizes' protections for clinical trial participants

19-Jan-2017 - The HHS issued a final rule updating outdated regulations to provide enhanced protection for clinical research participants – and the FDA may follow suit.

Q&A with CEO and CMO

Medical marijuana chewing gum to treat IBS in Dutch trial

18-Jan-2017 - AXIM Biotechnologies, Inc. will start 40-person clinical trial in the Netherlands for a mint-flavoured medical marijuana chewing gum to treat Irritable bowel syndrome (IBS). 


Servier universal CAR-T therapy outsourced to Belgian CDMO

18-Jan-2017 - Servier has recruited CDMO MaSTherCell SA to manufacture its universal CAR-T candidate UCART19, licensed from the biotech Cellectis as an off-the-shelf cell therapy for leukemia.

CROS NT: India an 'important and strategic market'

18-Jan-2017 - CROS NT has opened a new office in Bangalore, India as it looks to expand its clinical, regulatory, and data services lines to meet client demand.

News in brief

Evotec to provide drug discovery services as part of newly-formed Fibrocor Therapeutics

18-Jan-2017 - Evotec AG and MaRS Innovation have launched Fibrocor Therapeutics LP – a new company which will focus on developing first-in-class therapeutics targeting fibrotic diseases.

Paragon Bioservices secures NIAID contract for preclinical work

18-Jan-2017 - A pool of contractors will compete for task orders as part of the NIAID's preclinical drug development services contract to develop therapeutics for a range of global infectious diseases. 

McKesson to pay $150m after alleged failure to report suspicious orders

17-Jan-2017 - The distribution giant, McKesson Corporation, has agreed to pay the DEA's record fine of $150m after allegedly failing to report “suspicious orders” for controlled substances.


The rise of 'technology-enabled' clinical research companies

17-Jan-2017 - Technology is catapulting clinical trials into a 'new era' as scientific breakthroughs bring new opportunities to an industry that has traditionally lacked innovation.

Exco InTouch receives data security certification

17-Jan-2017 - Exco InTouch has formally received certification demonstrating it meets certain data privacy and security principles.

News in brief

Rho implements Phlexglobal eTMF solution

17-Jan-2017 - The Chapel Hill, NC-based contract research organization (CRO) has implemented PhlexEview4 as its preferred eTMF solution to support commercial and government clients.

Horizon to use CRISPR tech to enhance CHO cell lines for biomanufacturing

17-Jan-2017 - Horizon Discovery Group has extended its CRISPR technology license to improve the performance of CHO cell lines for biomanufacturing.

Poor provider engagement drives low patient recruitment, says Tufts

16-Jan-2017 - Poor communication between healthcare providers and clinical research professionals is contributing to low recruitment rates, according to a recent study by Tufts.

Exova adds 3-years to GSK environmental monitoring contract

16-Jan-2017 - GSK has renewed an environmental monitoring contract with Exova across manufacturing sites in the UK and Ireland.

New CRO Helomics partners up on prostate cancer liquid biopsies

16-Jan-2017 - Helomics has signed a deal with the diagnostics firm MDNA Life Sciences Inc., to help further develop MDNA’s liquid biopsy platform and commercialize its tests for prostate cancer.


CDMO Fujifilm adopts procurement automation solution

12-Jan-2017 - FUJIFILM Diosynth Biotechnologies USA (FDBU) has selected SciQuest to automate ‘critical’ purchasing and accounts payable processes.

News in brief

LabCorp to acquire Mount Sinai assets

12-Jan-2017 - The asset acquisition adds seven patient service centers to LabCorps’ network of 120 patient service centers in the metropolitan New York City area.

Drug formulary looks to accelerate clinical trial start up

12-Jan-2017 - The “NCI Formulary” enables investigators to obtain investigational agents for testing in new preclinical or clinical studies.

Certara updates population-based simulator

12-Jan-2017 - The updated Simcyp Simulator features several enhanced models to help predict pharmacokinetic outcomes in virtual patient populations.

Aerie to build manufacturing facility in Ireland

11-Jan-2017 - Aerie Pharmaceuticals Inc will lease a 30,000 sq ft manufacturing facility in Ireland to commercialise its eye-drop product for Glaucoma after delays at a third party CMO.


endpoint named preferred provider for Ferring Pharmaceuticals

11-Jan-2017 - Ferring Pharmaceuticals has selected endpoint as its sole leading interactive response technology (IRT) provider.

Catalent to assess resveratrol formulation across softgel platforms

11-Jan-2017 - Catalent will assess Jupiter Orphan Therapeutics’ resveratrol across its softgel technologies in an effort to improve the bioavailability of the rare disease candidate.

Parexel: taking steps to reduce costs with company-wide restructuring

11-Jan-2017 - Parexel’s restructuring plan to ‘simplify the organization’ will include eliminating an undisclosed amount of positions as the CRO looks to save on costs.

Pharmaron acquires Xceleron as it looks to provide 'end-to-end' services

11-Jan-2017 - Pharmaron’s acquisition of Xceleron further supports early discovery, preclinical and clinical development with expanded radiolabeled sciences capabilities.

« Previous month

Key Industry Events


Access all events listing

Our events, Shows & Conferences...